BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 19021025)

  • 1. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicardipine: a hypotensive dihydropyridine-type calcium antagonist with a peculiar cerebrovascular profile.
    Amenta F; Tomassoni D; Traini E; Mignini F; Veglio F
    Clin Exp Hypertens; 2008 Nov; 30(8):808-26. PubMed ID: 19021030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicardipine use in cerebrovascular disease: a review of controlled clinical studies.
    Amenta F; Lanari A; Mignini F; Silvestrelli G; Traini E; Tomassoni D
    J Neurol Sci; 2009 Aug; 283(1-2):219-23. PubMed ID: 19303080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel blockers and stroke.
    Inzitari D; Poggesi A
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
    Di Mascio R; Marchioli R; Tognoni G
    Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on calcium antagonists in cerebrovascular diseases.
    Toni D; Frontoni M; Argentino C; Sacchetti ML; De Michele M; Fieschi C
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S10-4. PubMed ID: 1726729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of nimodipine for prevention and treatment of cerebral arterial spasm in patients with subarachnoid hemorrhage.
    Welty TE
    Clin Pharm; 1987 Dec; 6(12):940-6. PubMed ID: 3322639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of nimodipine on the cerebral blood flow and intracranial pressure.
    Gaab MR; Haubitz I; Brawanski A; Korn A; Czech T
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():93-9. PubMed ID: 4010872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium channel blockers in therapy of neurologic diseases].
    Wessely P; Wöber-Bingöl C
    Wien Med Wochenschr; 1993; 143(19-20):514-8. PubMed ID: 8135034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of nimodipine on regional cerebral blood flow, brain water and electrolyte contents in rats with subarachnoid hemorrhage.
    Sun BL; Zhang SM; Xia ZL; Yang MF; Yuan H; Zhang J; Xiu RJ
    Clin Hemorheol Microcirc; 2003; 29(3-4):337-44. PubMed ID: 14724359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists in the management of subarachnoid haemorrhage.
    Robinson MJ; Teasdale GM
    Cerebrovasc Brain Metab Rev; 1990; 2(3):205-26. PubMed ID: 2223432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New aspects of calcium antagonists for treatment of cerebrovascular disease.
    Hennerici MG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S59-63. PubMed ID: 1725006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and treatment of subarachnoid hemorrhage.
    Welty TE; Horner TG
    Clin Pharm; 1990 Jan; 9(1):35-9. PubMed ID: 2406101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with nimodipine in the prophylaxis of neurological deficits after subarachnoid hemorrhage.
    Kazner E; Sprung C; Adelt D; Ammerer HP; Karnick R; Baumann H; Böker DK; Grotenhuis JA; Jaksche H; Istaitih AR
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():110-3. PubMed ID: 4010865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists and vasospasm.
    Meyer FB
    Neurosurg Clin N Am; 1990 Apr; 1(2):367-76. PubMed ID: 2136149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citicoline: pharmacological and clinical review, 2006 update.
    Secades JJ; Lorenzo JL
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimodipine in subarachnoid hemorrhage.
    DiPalma JR
    Am Fam Physician; 1989 Dec; 40(6):143-5. PubMed ID: 2686374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.